BioNTech SE (BNTX) Misses Q2 EPS by 19c; reaffirms guidance

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of (EUR1.60), EUR0.19 worse than the analyst estimate of (EUR1.41). Revenue for the quarter came in at EUR260.8 million versus the consensus estimate of EUR137.9 million.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR1.7-2.2 billion, versus the consensus of EUR2.27 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview